![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Pharmanet Development Grp (MM) | NASDAQ:PDGI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 5.04 | 0 | 01:00:00 |
Emilio Ragosa, Esq. | Glenn R. Pollner, Esq. | |
Morgan, Lewis & Bockius LLP | Gibson, Dunn & Crutcher LLP | |
502 Carnegie Center | 200 Park Avenue | |
Princeton, New Jersey 08540 | New York, NY 10166 | |
(609) 919-6600 | (212) 351-4000 |
Transaction Valuation(1) | Amount of Filing Fee (2) | ||||
$47,725,000.00 | $1,880.00 | ||||
(1) | This tender offer statement relates to the exchange by PharmaNet Development Group, Inc. of its 8.00% Convertible Senior Notes Due 2014 plus additional consideration for any and all of its currently outstanding 2.25% Convertible Senior Notes Due 2024. Estimated for the purpose of determining the filing fee only, this amount is based on the exchange of all 2.25% Convertible Senior Notes Due 2024 for 8.00% Convertible Senior Notes Due 2014. | |
(2) | The amount of the filing fee, calculated in accordance with the Securities Exchange Act of 1934, as amended equals $39.30 for each $1,000,000 of value. The registration fee was previously paid in connection with the Registrants Registration Statement on Form S-4 filed on November 20, 2008. |
Amount Previously Paid: $1,880.00
|
Filing Parties: PharmaNet Development Group, Inc. | |
Form or Registration No.: 333-155496
|
Date Filed: November 20, 2008 |
Item 4. Terms of the Transaction | ||||||||
Item 12. Exhibits | ||||||||
SIGNATURE | ||||||||
EXHIBIT INDEX | ||||||||
EX-99.A.1.VIII: PRESS RELEASE |
2
PHARMANET DEVELOPMENT GROUP, INC. | ||||||
|
||||||
|
By: |
/s/
John P. Hamill
|
||||
Name: John P. Hamill | ||||||
Title: Chief Financial Officer and Executive Vice President |
3
(a)(1)(i)*
|
Prospectus and Offer to Exchange (included in the Registration Statement on Form S-4 filed on November 20, 2008 and incorporated herein by reference) | |
|
||
(a)(1)(ii)*
|
Form of Letter of Transmittal (incorporated herein by reference to Exhibit 99.1 to the Registration Statement on Form S-4 filed on November 20, 2008) | |
|
||
(a)(1)(iii)*
|
Form of Letter to Brokers, Dealers, Commercial Bank, Trust Companies and Other Nominees (incorporated herein by reference to Exhibit 99.2 to the Registration Statement on Form S-4 filed on November 20, 2008) | |
|
||
(a)(1)(iv)*
|
Form of Letter to Beneficial Holders (incorporated herein by reference to Exhibit 99.3 to the Registration Statement on Form S-4 filed on November 20, 2008) | |
|
||
(a)(1)(v)*
|
Guidelines for Certification of Taxpayer Identification Number on Substitute Form W-9 (incorporated herein by reference to Exhibit 99.5 to the Registration Statement on Form S-4 filed on November 20, 2008) | |
|
||
(a)(1)(vi)*
|
Press Release, dated November 20, 2008 (filed on Form 8-K on November 20, 2008 pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 13e-4(c) under the Securities Exchange Act of 1934) | |
|
||
(a)(1)(vii)*
|
Form of Indenture between the Issuer and U.S. Bank National Association (the Indenture) incorporated herein by reference to Exhibit 4.3 to the Registration Statement on Form S-4 filed on November 20, 2008) | |
|
||
(a)(1)(viii)
|
Press Release, dated December 18, 2008. | |
|
||
(d)(i)*
|
Form of Dealer Manager Agreement (incorporated herein by reference to Exhibit 1.1 to the Registration Statement on Form S-4 filed on November 20, 2008) | |
|
||
(d)(ii)*
|
Indenture, dated as of August 11, 2004, between the Company and Wachovia Bank, National Association, which was filed as Exhibit 4.1 to the Companys Form S-3 which was filed with the Securities and Exchange Commission on November 2, 2004, and is incorporated herein by this reference | |
|
||
(d)(iii)*
|
Registration Rights Agreement, dated as of August 11, 2004, which was filed as Exhibit 4.2 to the Companys Form S-3 which was filed with the Securities and Exchange Commission on November 2, 2004, and is incorporated herein by this reference | |
|
||
(d)(iv)*
|
Shareholder Rights Agreement, dated as of December 21, 2005, by and between the Company and Wachovia Bank, National Association, as Rights Agent, which was filed as Exhibit 4.1 to the Companys Form 8-A which was filed on December 28, 2005, and is incorporated herein by this reference | |
|
||
(d)(v)*
|
Amended and Restated 1999 Stock Plan, which was filed as an exhibit to the Companys Annual Report on Form 10-K for the year ended December 31, 2007, and is incorporated herein by this reference | |
|
||
(d)(vi)*
|
Amended and Restated 2004 Employee Stock Purchase Plan, which was filed as an exhibit to the Companys Annual Report on Form 10-K for the year ended December 31, 2007, and is incorporated herein by this reference | |
|
||
(h)*
|
Opinion of Morgan, Lewis & Bockius, LLP as to certain U.S. federal income tax matters (incorporated by reference to Exhibit 8.1 of the Registration Statement on Form S-4 filed on November 20, 2008) |
* | Previously filed. |
4
1 Year Pharmanet Development Grp (MM) Chart |
1 Month Pharmanet Development Grp (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions